Navigation Links
Skin Medication Matrix Targets Venous Leg Ulcer Healing in New USA Clinical Trial
Date:9/22/2017

The effectiveness of a new wound healing skin medication for venous leg ulcers is now being assessed in clinical trials in the United States. (clinicaltrials.gov : NCT02973893)

To find out more about this clinical trial please talk to your nurse or physician or find your nearest participating clinic here https://factor-therapeutics.com/clinical-trials/ and discuss your condition with one of the medical team.

The new treatment, VF001-DP, is a synthetic skin medication that attaches to the base of the ulcer and creates a microscopic scaffold matrix which encourages the body’s skin cells to move into the wound and regrow skin layers.

Venous ulcers account for 70%–90% of ulcers found on the lower leg, and cost the health system $3.5 billion each year.

Up to one-third of all patients with venous ulcers have recurring wounds, some up to four or more times.

Most sufferers are over 40 years old and are cared for in more than 1,000 out-patient wound care centers in the United States.

The clinical trial, VF00102, is open to 168 people over the age of 18 with non-healing venous ulcers who meet the eligibility criteria – these include:
1. a small ulcer (approx. size of a Dime) that has been there for more than 6 months; or
2. a larger one that has been there for less than 6 months

The company, Factor Therapeutics Limited (ASX:FTT), previously ran a 53-patient trial where one-third of the ulcers healed in 12 weeks, with another half reducing in size by at least 70 per cent.

Participants will have a two-week screening period, then randomised patients will be treated weekly for 12 weeks, with a 12-week follow-up period. All patients enrolled in the study will also receive high quality standard care as part of the trial.

To find out more about this clinical trial please talk to your nurse or physician or find your nearest participating clinic here https://factor-therapeutics.com/clinical-trials/ and discuss your condition with one of the medical team.

Qualified participants will receive all trial related care and financial compensation for time and travel. No insurance is required.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14716475.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. In Focus with Martin Sheen Showcasing How Medication is Helping Win the Fight Against Mood Disorders
2. Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol"
3. Piedmont Pharmaceuticals Gains FDA Approval of Animal Health Soft Chew Pain Medication
4. Global Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline: MarketResearchReports.Biz
5. National Institute on Drug Abuse Awards SRI International Contract to Test Safety of Medications for Treatment of Substance Abuse
6. Elsevier Delivers Unified Medication Management Platform in China
7. Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication
8. Ten-year study highlights sleep deficiency and sleep medication use in astronauts
9. Increasing Per Capita Spends on Pet Healthcare Drives the Global Animal Medication Market, According to New Report by Global Industry Analysts, Inc.
10. Lawrence Livermore National Laboratory Partners with UC Davis to Personalize Cancer Medications
11. Proove Biosciences Launches World’s First Test to Predict Responders to Opioid Pain Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... 2017 International research firm Parks Associates announced today ... the TMA 2017 Annual Meeting , October 11 in ... home security market and how smart safety and security products impact the ... Parks Associates: Smart Home Devices: ... "The residential security market has experienced ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... of 13 prestigious awards honoring scientists who have made outstanding ... a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for ...
(Date:10/9/2017)... ... October 09, 2017 , ... At its national board meeting in North Carolina, ... Harvard University’s Departments of Physics and Astronomy, has been selected for membership in ... team for the 2015 Breakthrough Prize in Fundamental physics for the discovery of the ...
Breaking Biology Technology:
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
Breaking Biology News(10 mins):